ABSTRACT. We introduce a mathematical model of the in vivo progression of Alzheimer's disease with focus on the role of prions in memory impairment. Our model consists of differential equations that describe the dynamic formation of β-amyloid plaques based on the concentrations of Aβ oligomers, PrP C proteins, and the Aβ-×-PrP C complex, which are hypothesized to be responsible for synaptic toxicity. We prove the well-posedness of the model and provided stability results for its unique equilibrium, when the polymerization rate of β-amyloid is constant and also when it is described by a power law.
1. INTRODUCTION 1.1. What is the link between Alzheimer disease and prion proteins? Alzheimer's disease (AD) is acknowledged as one of the most widespread diseases of age-related dementia with ≈ 35.6 million people infected worldwide (World Alzheimer Report 2010 [40] ). By the 2050's, this same report has predicted three or four times more people living with AD. AD affects memory, cognizance, behavior, and eventually leads to death. Apart from the social dysfunction of patients, another notable societal consequence of AD is its economic cost (≈ $422 billion in 2009 [40] ). The human and social impact of AD has driven extensive research to understand its causes and to develop effective therapies. Among recent findings are the results that imply cellular prion protein (PrP C ) is connected to memory impairment [7, 8, 17, 23, 27] . This connection is the focus of our modeling here, which we hope will contribute to understanding the relation of AD to prions.
The pathogenesis of AD is related to a gradual build-up of β-amyloid (Aβ) plaques in the brain [13, 20] . β-amyloid plaques are formed from the Aβ peptides obtained from the amyloid protein precursor (APP) protein cleaved at a displaced position. There exist different forms of β-amyloids , from soluble monomers to insoluble fibrillar aggregates [5, 25, 26, 37, 39] . It has been revealed that the toxicity depends on the size of these structures and recent evidence suggest that oligomers (small aggregates) play a key role in memory impairment rather than β-amyloid plaques (larger aggregates) formed in the brain [35] . More specifically, Aβ oligomers cause memory impairment via synaptic toxicity onto neurons. This phenomenon seems to be induced by a membrane receptor, and there is evidence that this rogue agent is the PrP C protein [17, 23, 28, 32, 33] We note that this protein, when misfolded in a pathological form called PrP Sc , is responsible for Creutzfeldt-Jacob disease. Indeed, it is believed that there is a high affinity between PrP C and Aβ oligomers, at least theoretically [16] . Moreover, the prion protein has also been identified as an APP regulator, which confirms that both are highly related [28, 38] . This discovery offers a new therapeutic target to recover memory in AD patients, or at least slow memory depletion [6, 14] .
What is our objective?
Our objective here is to introduce and study a new in vivo model of AD evolution mediated by PrP C proteins. To the best of our knowledge, no model such as the one proposed here, has yet been advanced. There exist a variety of models specifically designed for Alzheimer's disease and their treatment, such as in [1, 3, 4, 10, 11, 15, 18, 19, 24, 31, 36] . Nevertheless, the prion protein has never been taken into account in the way we formulate here, and our model could helpful in designing new experiments and treatments.. This paper is organized as follows. We present the model in section 2, and provide a well-posedness result in the particular case that β-amyloids are formed at a constant rate. In section 3 we provide a theoretical study of our model in a more general context with a power law rate of polymerization, i.e. the polymerization or build-up rate depends on β-amyloid plaque size.
2. THE MODEL 2.1. A model for beta-amyloid formation with prions. The model deals with four different species. First, the concentration of Aβ oligomers consisting of aggregates of a few Aβ peptides; second, the concentration of the PrP C protein; third, the concentration of the complex formed from one Aβ oligomer binding onto one PrP C protein. These quantities are soluble and their concentration will be described in terms of ordinary differential equations. Fourth, we have the insoluble β-amyloid plaques described by a density according to their size x. This approach is standard in modeling prion proliferation phenomena (see for instance [4, 18, 30] ). Note that the size x is an abstract variable that could be the volume of the aggregate. Here, however, we view aggregates as fibrils that lengthen in one dimension. The size variable x thus belongs to the interval (x 0 , +∞), where x 0 > 0 stands for a critical size below which the plaques cannot form. To summarize we denote, for x ∈ (x 0 , +∞) and t ≥ 0, f (t, x) ≥ 0 : the density of β-amyloid plaques of size x at time t, Note that β-amyloid plaques are formed from the clustering of Aβ oligomers. The rate of agglomeration depends on the concentration of soluble oligomers and the structure of the amyloid which is linked to its size. It occurs in a mass action between plaques and oligomers at a nonnegative rate given by ρ(x), where x is the size of the plaque. This is the reason why the intentionally misused word "size" considered here (and described above) accounts for the mass of Aβ oligomers that form the polymer. We assume indeed, that the mass of one oligomer is given by a "sufficiently small" parameter ε > 0. Thus, the number of oligomers in a plaque of mass x > 0 is x/ε which justifies our assumption that the size of plaques is a continuum. Moreover, amyloids have a critical size x 0 = εn > 0, where n ∈ N * is the number of oligomers in the critical plaque size. The amyloids are prone to be damaged at a nonnegative rate µ, possibly dependent on the size x of the plaques. All the parameters for Aβ oligomers, PrP C , and β-amyloid plaques, such as production, binding and degradation rates, are nonnegative and described in table 2.1.
Then, writing evolution equations for these four quantities, we obtain The term N accounts for the formation rate of a new β-amyloid plaque with size x 0 from the Aβ oligomers. In order to balance this term, we add the boundary condition
The integral in the right-hand side of equation (2) is the total polymerization with parameters1/ε, since dx/ε counts the number of oligomers into a unit of length dx. Finally, the problem is completed with nonnegative initial data, a function f in ≥ 0 and u in , p in , b in ≥ 0, such that at time
and
The above system (1-5) involves two formal balance laws: the first one for prion proteins
and the second for Aβ oligomers
The total concentrations of both evolve in time according to the production and degradation rates. In figure 1 we give a schematic representation of these processes.
2.
2. An associated ODE system. In this section we investigate constant polymerization and degradation rates, i.e, rates independent of the size of the plaque involved in the process. This first approach is biologically less realistic, but technically more tractable, yet still quite challenging for an analytical study of the problem. In section 3, the polymerization rate ρ will be taken more realistically as a power of x. Here we assume that ρ(x) := ρ and µ(x) := µ are positive constants. Moreover, without loss of generality, we let ε = 1, which only requires a rescaling of the units in the equations. Then, we assume a pre-equilibrium hypothesis for the formation of β-amyloid plaques, as formulated in [29] for filaments, by setting N(u) = αu n . The formation rate is given by α > 0 and the number of oligomers necessary to form a new plaque is an integer, n ≥ 1. With these assumptions we are able to close the system (1-4) with respect to (5) into a system of four differential equations. Indeed, integrating (1) over (x 0 , +∞) we get formally an equation over the quantity of amyloids at time t ≥ 0
This method has already been used on the prion model in [18] . Now the problem reads, for t ≥ 0,
The mass of β-amyloid plaques is given by
x f (x,t)dx which satisfies an equation (formal integration of (1)) that can be solved independently, sincė
Notice that initial conditions for A and M are given by
x f in (x)dx, while the initial conditions for u, p and b are unchanged.
The next subsection is devoted to the analysis of the system (8-11).
2.3.
Well-posedness and stability of the ODE system. We prove in the following proposition the positivity, existence, and uniqueness of a global solution to the system (8-11) with classical techniques from the theory of ordinary differential equations( [21] ).
Proposition 1 (Well-posedness). Assume λ u , λ p , γ u , γ p , τ, σ, δ, ρ and µ are positive, and let n ≥ 1 be an integer. For any (A in , u in , p in , b in ) ∈ R 4 + there exists a unique nonnegative bounded solution (A, u, p, b)
to the system (8-11) defined for all time t > 0, i.e, the solution A, u, p and b belong to C 1 b (R + ) and remains in the stable subset
with λ = λ u + λ p and m = min{µ, γ u , γ p , δ}. Furthermore, let M(t = 0) = M in ≥ 0, and then there exist a unique nonnegative solution M to (12) , defined for all time t > 0.
Proof. Let F : R 4 → R 4 be given by
F is obviously C 1 and locally Lipschitz continuous on + . Finally, we remark that
with λ = λ u + λ p and m = min {µ, γ u , γ p , δ} > 0, and Gronwall's lemma ensures that
This proves the global existence of a unique nonnegative bounded solution (A, u, p, b). The claim for the mass M is straightforward.
We next consider the existence of a steady state A ∞ , u ∞ , p ∞ , b ∞ and the asymptotic behavior of solutions to (8) (9) (10) (11) . It is easy to compute the steady state by solving the problem
From the structure of the second equation, we cannot give an explicit formula for this problem. To obtain u ∞ we have to solve an algebraic equation, which involves a polynomial of degree n. However, we can prove that the solution exists, and then u ∞ is given implicitly. The next proposition establishes the local stability of the steady state..
Theorem 2 (Linear stability).
Under hypothesis of proposition 1, there exists a unique positive steady state A ∞ , u ∞ , p ∞ and b ∞ to (8-11) with
where τ * = τ(1 − σ/(δ + σ) and u ∞ is the unique positive root of Q, defined by
Moreover, this equilibrium is locally linearly asymptotically stable.
Proof. First, equation (14) gives A ∞ with respect to u ∞ . Then, combining (16) and (17) we get p ∞ and b ∞ as functions of u ∞ . Now replacing p ∞ and b ∞ in (15) we get u ∞ as the root of Q. It is straightforward that Q has a unique positive root. Indeed, it is the intersection between a line and a monotonic polynomial on the half plane. Now, we linearize the system in A ∞ , u ∞ , p ∞ and b ∞ . Let X = (A, u, p, b) T and the linearized system reads
The characteristic polynomial is of the form
with the a i > 0, i = 1 . . . 4 given in the appendix. Moreover it satisfies a 1 a 2 a 3 > a , all the roots of the characterisic polynomial P are negative or have negative real part, thus the equilibrium is locally asymptotically stable.
To go further, we give a conditional global stability result when no nucleation is considered, i.e., α = 0.
Proposition 3 (Global stability). Assume that α = 0. Under the condition
the unique equilibrium is given by
where u ∞ is the unique positive root of
Further, this equilibrium is globally asymptotically stable in the stable subset S defined in (13).
Proof. The proof is given by a Lyapunov function Φ stated in the appendix. It is positive when the condition above is fulfilled and its derivative along the solution to the system (8-11) is negative definite. Thus, from the LaSalle's invariance principle, we get that under these hypotheses the equilibrium of (8-11) is globally asymptotically stable.
A POWER LAW POLYMERIZATION RATE
The assumption that the polymerization rate ρ and the degradation rate µ are constant is not always biologically realistic, as recognized in [3, 15] . Consequently, we study here the more realistic case ρ(x) ∼ x θ , and in the following we restrict our analysis to θ ∈ (0, 1). We will see that we are able to obtain a result of existence and uniqueness of solutions for this more general case.
3.1. Hypotheses and main result. We are interested in nonnegative solutions to the system (1-4) with the boundary condition (5), completed by initial data (6) and (7), but with the new assumption ρ(x) ∼ x θ . Moreover, we require that our solution preserves the total mass of β-amyloid in order to be biologically relevant. Hence, the solution f will be sought in the natural space L 1 (x 0 , +∞; xdx), since xdx measures the mass at any time. Our hypotheses for the system (1-4) are
We note that (H2) implies the existence of a constant C > 0 such that ρ(x) ≤ Cx, with for example,
We remark that this kind of regularity of the rate ρ covers the case that ρ(x) ∼ x θ with θ ∈ (0; 1). Also, Then a quadruplet ( f , u, p, b) of nonnegative functions is said to be a solution on the interval (0, T ) to the system (1-4) with the boundary condition (5) and the initial data (6) and (7), if it satisfies, for any
with the regularity f ∈ L ∞ 0, T ; L 1 (x 0 , +∞; xdx) and u, p, b ∈ C 0 (0, T ).
Theorem 4 (Well-posedness). Let f in be a nonnegative function satisfying (H1), let u in , p in and b in be nonnegative real numbers, and assume hypothesis (H2) to (H4). Let T > 0. There exists a unique nonnegative solution ( f , u, p, b) to (1-4) with (5) and initial conditions given by (6) and (7), in the sense of definition 1, such that f
The proof of the theorem 4 is decomposed into two parts. First, we study the initial boundary value problem
We prove in the subsection 3.2 the following proposition:
, let f in satisfy (H1), and assume hypothesis (H2) to (H3). For any T > 0, there exists a unique nonnegative solution f to (18) (19) (20) in the sense of distributions, such that
The proof is in the spirit of the proof in [9] for the Lifshitz-Slyozov equation. It consists of a proof based on the concept of a mild solution in the sense of distributions, with the additional requirement of continuity from time into L 1 (xdx) space.
The second step of the proof of theorem 4 is performed in subsection 3.3. Precisely, once we have the existence of a unique density f , when u is given, we are able to construct the operator
where f is the unique solution associated to u given by proposition 5. Then, theorem 4 is finally proven in subsection 3.3 applying the Banach fixed point theorem to the operator S.
Existence of a solution to the autonomous problem.
In the following we let u ∈ C 0 b (R + ) and we use the notations a(x,t) = u(t)ρ(x) and c(x,t) = −u(t)ρ (x) for every (x,t) ∈ [x 0 , +∞) × R + . From (H2) and noting that ρ(x) ≤ Cx, we have for any t > 0
where
. In order to establish the mild formulation of the problem, we define the characteristic which reaches x ≥ x 0 at time t ≥ 0, that is, the solution to d ds X(s; x,t) = a(t, X(s; x,t)),
From property (23) , their exists a unique characteristic that reaches (x,t).We note that it makes sense as long as X(s; x,t) ≥ x 0 . Thus, we define the starting time of the characteristic as
The characteristic will be defined for any time s ≥ s 0 and takes its origin from the initial or the boundary condition, respectively, if s 0 = 0 or s 0 > 0. We recall the classical properties of these characteristics X(s; X(σ; x,t), σ) = X(s; x,t) J(s; x,t) := ∂ ∂x X(s; x,t) = exp t s c(σ, X(σ; x,t))dσ ∂ ∂t X(s; x,t) = −a(t, x)J(s; x,t).
Also, remarking that s 0 (X(t; x 0 , 0),t) = 0, then by monotonicity and continuity of X for any t > 0, we get x ∈ (x 0 , X(t; x 0 , 0)) ⇐⇒ s 0 (x,t) ∈ (0,t), and for any x ∈ (x 0 , X(t; x 0 , 0)) we have X(s 0 (x,t); x,t) = x 0 .
It follows that for every x ∈ (x 0 , X(t; x 0 , 0))
Considering the derivative of f (s, X(s; x,t)) in s, and integrating over (s 0 ,t) we obtain the mild formulation of the problem. The mild solution is defined for a.e. (x,t) ∈ (x 0 , +∞) × R + by
We infer from the formulation (26) that for a.e (x,t) ∈ [x 0 , +∞) × R + , f is nonnegative, since J and I are nonnegative, and f in satisfies (H1). We recall some useful properties that are derived in [9, Lemma 1].
Lemma 6. Let u ∈ C 0 b (R + ) be a given data and assume that (H2) holds. Then for any x ≥ x 0 and t > 0, as long as the characteristic curve s → X(s; x,t) defined in (25) exists, i.e., s ≥ s 0 (x,t), we have
Proof. We refer to [9, Lemma 1] , where the result follows from the fact that for any x ≥ x 0 , t > 0 and s 0 (x,t) ≤ s 1 ≤ s 2 , we have
where A is given by (22) .
In the sequel we will repeatedly refer to the changes of variables y = X(0; x,t) over x ∈ (X(t, x 0 , 0), +∞), with Jacobian J(0; x,t), s = s 0 (x,t) over x ∈ (x 0 , X(t; x 0 , 0)), with Jacobian − I(x,t).
The first is a C 1 -diffeomorphism from (X(t, x 0 , 0), +∞) into (x 0 , +∞), and the second from (x 0 , X(t; x 0 , 0)) into (0,t). Integrating f defined by (26) over (0, R) with R > X(t; x 0 , 0), using the change of variables above, using lemma 6, and taking the limit R → +∞, we get
where we have split the integral into two parts and uses both the previous changes of variables. Thus,for any
In the next lemma we claim that f defined by (26) is a weak solution.
Lemma 7. Let f be the mild solution defined by (26) . Then for any t > 0 
by the same change of variable made above for (27) . Furthermore, we have
still using the change of variable mentioned above and
Finally, combining (28), (29) and (30) we obtain that f is a weak solution.
The aim of the following lemma is to prove that the moments of f less than 1 are continuous in time.
Lemma 8. Let hypothesis (H1) to (H3) hold. Let f be the mild solution given by (26) . Then for any
, we have for any t > 0 and δt > 0
Our goal is to prove that each term goes to zero when δt goes to zero. We first bound I 3 , which results from the initial condition, since for x ≥ X(t + δt; x 0 , 0) ≥ X(t; x 0 , 0), it follows that
, xdx) to f in . We write I 3 as follows
µ(X(σ;x,t+δt))dσ dx,
Dropping the exponential term, which is bounded by one, and changing of variables y = X(0; x,t + δt) in I 1 3 and y = X(0; x,t) in I 3 3 , we get
AT +∞
with the help of lemma 6. Next we bound I 2 3 by and we denote the integrals by J 1 3 to J 3 3 , respectively. We remark that J(0, x,t) ≤ e BT by (24) and so
where C ε depends on T , A and R ε i.e., the compact support of f in ε . Then Thus, with (22) and (24),
where K is the Lipschitz constant of ρ . Since
and if |x| ≤ y, then
Thus, we get
Since µ is nonnegative,
Exactly as above,
From (32), (33), (34) and (35) we can conclude that for any ε > 0,
with lim ε→0 C 1 3 (T, ε) = 0 and lim δt→0 C 2 3 (T, δt, ε) = 0.
Next, concerning I 1 , f can be written from the boundary condition. Let
where A 1 is given by ( 
Proof. This estimation is obtained from a classical argument of approximation. Let h = f 1 − f 2 and
Let h ε be a regularization of h and S δ a regularization of the Sign function. Take
with g ∈ C ∞ c ([x 0 , +∞)). Then, letting δ → 0 and then ε → 0, we get
Finally, we approximate the identity function with a regularized function η R ∈ C ∞ c ([x 0 , +∞)) such that η R (x) = x over (0, R), and then taking the limit R → +∞ ends the proof.
We get straightforward from proposition 7 that f defined by (26) is a weak solution and the only one from proposition 9. Indeed, getting u 1 = u 2 and f 0 1 = f 0 2 in proposition 9 leads to the uniqueness. Finally, proposition 8 provides the continuity in time of the moments with order less or equal to one. This concludes the proof of proposition 5 3.3. Proof of the well-posedness. In this section we prove theorem 4. We first study the operator S in (21).
Lemma 10. Consider hypothesis (H2) to (H4). Let u in , p in and b in be nonnegative initial data, and let f in satisfy (H1). Let M > 0 be large enough such that u in , p in , b in < M/2 and define
is equipped with the uniform norm. Then, there exists T > 0 (small enough) such that
Proof. Let M be sufficiently large such that max(u in , p in , b in ) < M/2, and let T > 0 be small enough such that
where C 1 (M) is the Lipschitz constant of N on (0, M) and
where C is the constant such that ρ(x) ≤ Cx, see (27) . This assumption ensures that for any (u, p, b) ∈ X M , then S(u, p, b) ∈ X M , i.e, the solution is bounded by M and is nonnegative. It remains to prove that S is a contraction. Let (u 1 , p 1 , b 1 ) and (u 2 , p 2 , b 2 ) belong to X M . Then
Then,
and from Proposition 9,
We get similar bounds for
We infer that there exists a constant C(M, T ) depending only on M and T such that
with C(M, T )T → 0, when T goes to 0. Hence, if T is small enough such that C(M, T )T < 1 , then S is a contraction.
From Lemma 10, we have a local nonnegative solution on [0, T ], which is unique with the solution (u, p, b) bounded by the constant M. The solution satisfies f ∈ C 0 (0, T ; L 1 (xdx)) and u, p, b ∈ C 0 (0, T ). with m = min(γ u , γ p , δ) and λ = λ u + λ p . Using Gronwall's lemma, the solutions remain bounded, at any time by
From this global bound on u, p and b, we can construct the solution on any interval of time by repetition of the local argument. The proof of the theorem is complete.
SUMMARY
The connection of prions and AD is not fully understood, but recent research suggests that soluble Aβ oligomers are possible inducers of AD neuropathology. The key element of this hypothesis is that β−amyloid plaques increase their size over disease progression by the clustering of Aβ oligomers, which are bound to PrP C proteins. Aβ oligomers exist both as bounded and unbounded to PrP C proteins, and the agglomerartion rate in the formation of β−amyloid plaques depends on the concentrations of the bound and unbound Aβ oligomers, the concentration of soluble PrP C , and the size of the β−amyloid plaques. We have introduced a mathematical model of the evolution of AD based on these hypotheses, and presented a mathematical analysis of its fundamental properties. Specifically, we have analyzed in detail the existence and uniqueness properties of solutions, as well as the qualitative properties of solution behavior. In specific cases we have quantified the stabilization of the solutions to steady state, a well-known feature of AD progression. In future work we will explore applications of this model to specific AD laboratory and clinical data.
APPENDIX A. CHARACTERISTIC POLYNOMIALS OF THE LINEARIZED ODE SYSTEM
Here we give the coefficient a i , i = 1, . . . , 4 for the characteristic polynomial of the linearized system in proposition 2: 
